SHERIDAN OLIVER: Open Payments
NPI 1770267312 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,379 in 160 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $257 · 2025 $2,379
Food & beverage: $2,297Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $481 |
| Regeneron Healthcare Solutions, Inc. | 14 | $301 |
| Janssen Biotech, Inc. | 24 | $256 |
| E.R. Squibb & Sons, L.L.C. | 32 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $252 |
| UCB, Inc. | 10 | $191 |
| LEO Pharma Inc. | 10 | $166 |
| Organon LLC | 13 | $98 |
| Lilly USA, LLC | 5 | $95 |
| Incyte Corporation | 3 | $71 |
Products named: TREMFYA, Sotyktu, DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, ILUMYA, Winlevi.
Industry payments across CO — which companies pay providers there.
